Lung cancer in idiopathic pulmonary fibrosis

被引:0
|
作者
Kreider, Maryl [1 ]
机构
[1] Univ Penn, Perelman Sch Med, 0828 Maloney Bldg,3400 Spruce St, Philadelphia, PA 19104 USA
关键词
Lung cancer; Idiopathic pulmonary fibrosis; Prevalence; Relativerisk; Riskfactors; Prognosis; Therapy; Acute exacerbation;
D O I
10.1007/s13665-013-0060-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Lung cancer appears to be more common among patients with idiopathic pulmonary fibrosis (IPF). The exact prevalence is unclear but is likely to be in the range 5-17 %. Risk factors for lung cancer in IPF include age, greater smoking history, and male gender. Squamous cell lung cancer may be more common in IPF than in the general population. The lung cancers are more often at the periphery and bases, although these findings are not universal. The pathogenesis behind this increased association is unknown but may be because of increased cell turnover and DNA damage. The development of lung cancer often is a late complication and the effect of this diagnosis on an individual's outcome is unknown. However, IPF affects patients' therapeutic options, both their ability to tolerate intervention and because of a significant risk of acute exacerbation after the intervention.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 50 条
  • [1] Lung cancer in idiopathic pulmonary fibrosis
    Maryl Kreider
    [J]. Current Respiratory Care Reports, 2013, 2 (4): : 248 - 253
  • [2] Lung cancer in patients with idiopathic pulmonary fibrosis
    Park, J
    Kim, DS
    Shim, TS
    Lim, CM
    Koh, Y
    Lee, SD
    Kim, WS
    Kim, WD
    Lee, JS
    Song, KS
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (06) : 1216 - 1219
  • [3] Lung cancer in patients with idiopathic pulmonary fibrosis
    Karampitsakos, Theodoros
    Tzilas, Vasilios
    Tringidou, Rodoula
    Steiropoulos, Paschalis
    Aidinis, Vasilis
    Papiris, Spyros A.
    Bouros, Demosthenes
    Tzouvelekis, Argyris
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 : 1 - 10
  • [4] Idiopathic pulmonary fibrosis will increase the risk of lung cancer
    Li Junyao
    Yang Ming
    Li Ping
    Su Zhenzhong
    Gao Peng
    Zhang Jie
    [J]. 中华医学杂志(英文版), 2014, (17) : 3142 - 3149
  • [5] The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
    Tomassetti, Sara
    Gurioli, Christian
    Ryu, Jay H.
    Decker, Paul A.
    Ravaglia, Claudia
    Tantalocco, Paola
    Buccioli, Matteo
    Piciucchi, Sara
    Sverzellati, Nicola
    Dubini, Alessandra
    Gavelli, Giampaolo
    Chilosi, Marco
    Poletti, Venerino
    [J]. CHEST, 2015, 147 (01) : 157 - 164
  • [6] Primary lung cancer in patient with idiopathic pulmonary fibrosis
    Kang, Heon Hui
    Kim, Jin Woo
    Lee, Sang Haak
    Moon, Hwa Sik
    Ahn, Joong Hyun
    Park, Chan Kwon
    Kim, Myung Sook
    Kim, Ju Sang
    Kim, Young Kyoon
    Ko, Yoon Ho
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S429 - S430
  • [7] Clinical features of idiopathic pulmonary fibrosis with lung cancer
    Uematsu, K
    Seike, M
    Yoshimura, A
    Shibuya, M
    Kudoh, S
    Kiyoshi, T
    Kamio, K
    Okano, T
    Watanabe, S
    Yamamoto, K
    Hasegawa, K
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A64 - A64
  • [8] Treatment Outcomes of Lung Cancer in Idiopathic Pulmonary Fibrosis
    Yoo, H.
    Jeong, B.
    Kwon, O.
    Chung, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] LUNG-CANCER IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    NAGAI, A
    CHIYOTANI, A
    NAKADATE, T
    KONNO, K
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 167 (03): : 231 - 237
  • [10] Operative indications for lung cancer with idiopathic pulmonary fibrosis
    Kushibe, K.
    Kawaguchi, T.
    Takahama, M.
    Kimura, M.
    Tojo, T.
    Taniguchi, S.
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2007, 55 (08): : 505 - 508